چکیده مقاله
Background and Objective: Acute respiratory syndrome coronavirus 2 SARS CoV 2 was firstidentified in December 2019 as a novel respiratory pathogen and is the causative agent of coronavirusdisease 2019 COVID 19 Early in the pandemic, it became clear that SARS CoV 2 infection wasnot limited to infecting the respiratory tract, but that the virus was also found in other tissues,including blood vessels People who already have underlying co morbidities such as diabetes and highblood pressure are more susceptible to severe illness and fatal outcomes during COVID 19 Search Method: In this article, we review the results of articles related to vascular injuries in Covid 19 Using relevant articles available in reliable scientific databases such as PubMed, Scopus, ScienceDirect, Google Scholar, which were conducted between 2019 and 2022 Findings: In patients withCovid 19, numerous cardiovascular manifestations have been reported SARS CoV 2 infection canlead to inflammatory cardiovascular disease first through the acquisition of angiotensin convertingenzyme 2 as a cell receptor and also macrophage activation syndrome in severe disease In the studiesconducted, the ratio of blood pressure and cardiovascular diseases in patients with COVID 19 washigher than in the general population The incidence of high blood pressure and cardiovasculardiseases was about twice and three times, respectively, in critically ill patients hospitalized in ICUcompared to their non ICU counterparts Venous and arterial thrombosis are commonly associatedwith Covid 19, but in situ diagnosis of intracardiac thrombosis and large vessel involvement has beenreported infrequently Intracardiac thrombosis and embolization have a very high risk ofcomplications in covid 19 Although large vessel thrombosis LVT is rare in this disease, however,Covid 19 is a hidden risk factor for large vessel thrombosis that may be life threatening and lead toamputation Despite anticoagulation therapy, all patients with covid 19 are still at risk for LVT, andsurgical consultation should be considered if minimal symptoms occur Mild covid 19, withoutsignificant lung parenchymal involvement, can also cause LVT Create an overcoagulable state thatleads to venous thromboembolism VTE The virus can also lead to exacerbation of aproinflammatory state activation of cytokine storm , which in turn may lead to pulmonary vascularendotheliitis, microangiopathy, disseminated thrombosis, myocarditis, heart failure, cardiacarrhythmias, and acute syndromes become coronary All these events are especially seen in elderlypatients and require targeted cardiovascular treatments and specific management against COVID 19 Heart patients who have recovered from Corona are always under the threat of blood and vascularclots, which if they are in the person's body, will lead to the blackening of that part of the body, or inthe lungs in the form of a pulmonary embolism, in the heart vessels as a heart attack, and in thecerebral vessels It occurs as a delayed stroke Conclusion: The results of this article show that theconsequences of covid 19 disease are not limited to the lungs, but can go beyond and affect organsother than the lungs, especially the cardiovascular system, and increase the death rate caused by thisdisease Therefore, it is recommended The patient should be monitored for cardiovascularcomplications during hospitalization and after discharge from the hospital
کلیدواژهها
نویسندگان
Mohammad Hadi Sarvari
Instructor of Critical Care Nursing , Department of Nursing, Qaen School of Nursing and Midwifery ,Birjand University of Medical Sciences
Maryam Sadat Katebi
Instructor of Midwifery Education , Department of Midwifery, Qaen School of Nursing and Midwifery ,Birjand University of Medical Sciences
Halimeh Janpors
Master of Educational Sciences, Education and Treatment Center of Ghaen , Birjand University of MedicalSciences
شیوه ارجاع
Sarvari, Mohammad Hadi and Katebi, Maryam Sadat and Janpors, Halimeh,1401,Vascular injuries in covid 19,The 12th International Conference on Health, Treatment and Health Promotion
ارائهشده در
مجموعه مقالات دوازدهمین کنفرانس بین المللی بهداشت، درمان و ارتقای سلامت22 اسفند 1401